All in on AI, Accountable to Outcomes

Accountability is a cornerstone in our approach to Responsible AI.

Our Latest News

Our Science

May 22, 2024

Digital “Twinning”: Clinical Trials Powered by AI

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

Sanofi X Paris 2024

We’re proud to be premium partner of Paris 2024.

Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.

About Us

Who We Are

We are an innovative global healthcare company.

Our Pipeline


Therapeutic areas


Compounds in clinical development


Clinical trials in phase 3

Explore Career Opportunities

You'll be surprised what you can achieve at Sanofi. Discover your future here.

Our Latest Press Releases

May 22, 2024
Media Update: New results from rilzabrutinib phase 2 study show potential to be first advanced oral treatment for moderate-to-severe asthma
May 21, 2024
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
May 20, 2024
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
May 13, 2024
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty